Inactivated Poliovirus Vaccine Project

Release date:

2018-06-30

Author:

Source:


Abstract

Partner: The Netherlands’ INTRAVACC collaborative project on a human diploid cell–based rabies vaccine. Cooperation model: technology transfer, with support from the Major New Drug Development Program. Significance of the collaboration: to provide Chinese citizens with a safe and effective inactivated poliovirus vaccine (IPV), to achieve localized production of IPV, and to facilitate its inclusion in the national immunization program; at the same time, to enable the international market supply of IPV through the WHO.

Partner

Netherlands INTRAVACC

Collaboration Project

Inactivated Poliovirus Vaccine

Method of Cooperation

Technology transfer

Receive support

Support for the Development of Major New Drugs

Significance of Cooperation

Providing a safe and effective IPV vaccine to the Chinese population is of great significance for achieving localized production of the IPV vaccine and for promoting its inclusion in the national immunization program; at the same time, it will enable the supply of IPV vaccine to the international market through the WHO.

 

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09